Full Press Release Details
ASC40 (TVB-2640) Phase 2 NASH Trial Completed Patient Enrollment in China.
SGMT
ASC40 (TVB-2640) Phase 2 NASH Trial Completed Patient Enrollment in China
Key Takeaway: ASC40 (TVB-2640) Phase 2 NASH Trial Completed Patient Enrollment in China